NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway.
Cui S, Xia T, Zhao J, Ren X, Wu T, Kameni M, Guo X, He L, Guo J, Duperray-Susini A, Levillayer F, Collard JM, Zhong J, Pan L, Tangy F, Vidalain PO, Zhou D, Jiu Y, Faure M, Wei Y.
Cui S, et al.
Nat Commun. 2023 Dec 19;14(1):8440. doi: 10.1038/s41467-023-44201-2.
Nat Commun. 2023.
PMID: 38114531
Free PMC article.